Annual EBIT:
-$153.46M-$124.73M(-434.17%)Summary
- As of today, IMNM annual earnings before interest & taxes is -$153.46 million, with the most recent change of -$124.73 million (-434.17%) on December 31, 2024.
- During the last 3 years, IMNM annual EBIT has fallen by -$128.25 million (-508.86%).
- IMNM annual EBIT is now -1891.90% below its all-time high of -$7.70 million, reached on December 31, 2018.
Performance
IMNM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$46.48M-$1.84M(-4.13%)Summary
- As of today, IMNM quarterly earnings before interest & taxes is -$46.48 million, with the most recent change of -$1.84 million (-4.13%) on June 30, 2025.
- Over the past year, IMNM quarterly EBIT has dropped by -$12.78 million (-37.93%).
- IMNM quarterly EBIT is now -1650.58% below its all-time high of -$2.65 million, reached on March 31, 2020.
Performance
IMNM Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$190.53M-$12.78M(-7.19%)Summary
- As of today, IMNM TTM earnings before interest & taxes is -$190.53 million, with the most recent change of -$12.78 million (-7.19%) on June 30, 2025.
- Over the past year, IMNM TTM EBIT has dropped by -$118.00 million (-162.70%).
- IMNM TTM EBIT is now -6904.71% below its all-time high of -$2.72 million, reached on September 30, 2019.
Performance
IMNM TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
IMNM EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -434.2% | -37.9% | -162.7% |
| 3Y3 Years | -508.9% | -420.7% | -427.1% |
| 5Y5 Years | -1384.4% | -1611.9% | -1046.7% |
IMNM EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -508.9% | at low | -939.5% | +16.4% | -740.7% | at low |
| 5Y | 5-Year | -1384.4% | at low | -1092.7% | +16.4% | -1046.7% | at low |
| All-Time | All-Time | -1891.9% | at low | -1650.6% | +16.4% | -6904.7% | at low |
IMNM EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$46.48M(-4.1%) | -$190.53M(-7.2%) |
| Mar 2025 | - | -$44.64M(+19.7%) | -$177.75M(-15.8%) |
| Dec 2024 | -$153.46M(-434.2%) | -$55.60M(-26.9%) | -$153.46M(-37.4%) |
| Sep 2024 | - | -$43.82M(-30.0%) | -$111.71M(-54.0%) |
| Jun 2024 | - | -$33.70M(-65.6%) | -$72.53M(-62.6%) |
| Mar 2024 | - | -$20.34M(-46.9%) | -$44.60M(-55.3%) |
| Dec 2023 | -$28.73M(+22.1%) | -$13.85M(-199.0%) | -$28.73M(-26.8%) |
| Sep 2023 | - | -$4.63M(+19.7%) | -$22.66M(+14.7%) |
| Jun 2023 | - | -$5.77M(-29.1%) | -$26.57M(+10.6%) |
| Mar 2023 | - | -$4.47M(+42.6%) | -$29.72M(+19.5%) |
| Dec 2022 | -$36.90M | -$7.79M(+8.8%) | -$36.90M(+0.2%) |
| Sep 2022 | - | -$8.53M(+4.4%) | -$36.96M(-2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$8.93M(+23.4%) | -$36.15M(-9.7%) |
| Mar 2022 | - | -$11.65M(-48.6%) | -$32.96M(-30.8%) |
| Dec 2021 | -$25.20M(-41.6%) | -$7.84M(-1.6%) | -$25.20M(-17.7%) |
| Sep 2021 | - | -$7.72M(-34.5%) | -$21.42M(+2.9%) |
| Jun 2021 | - | -$5.74M(-47.3%) | -$22.07M(-15.9%) |
| Mar 2021 | - | -$3.90M(+4.1%) | -$19.04M(-7.0%) |
| Dec 2020 | -$17.80M(-72.2%) | -$4.06M(+51.5%) | -$17.80M(-7.1%) |
| Sep 2020 | - | -$8.37M(-208.2%) | -$16.61M(-51.5%) |
| Jun 2020 | - | -$2.71M(-2.3%) | -$10.97M(-32.9%) |
| Mar 2020 | - | -$2.65M(+7.7%) | -$8.25M(-47.4%) |
| Dec 2019 | -$10.34M(-34.2%) | -$2.88M(-5.8%) | -$5.60M(-105.8%) |
| Sep 2019 | - | -$2.72M | -$2.72M |
| Dec 2018 | -$7.70M | - | - |
FAQ
- What is Immunome, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Immunome, Inc.?
- What is Immunome, Inc. annual EBIT year-on-year change?
- What is Immunome, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Immunome, Inc.?
- What is Immunome, Inc. quarterly EBIT year-on-year change?
- What is Immunome, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Immunome, Inc.?
- What is Immunome, Inc. TTM EBIT year-on-year change?
What is Immunome, Inc. annual earnings before interest & taxes?
The current annual EBIT of IMNM is -$153.46M
What is the all-time high annual EBIT for Immunome, Inc.?
Immunome, Inc. all-time high annual earnings before interest & taxes is -$7.70M
What is Immunome, Inc. annual EBIT year-on-year change?
Over the past year, IMNM annual earnings before interest & taxes has changed by -$124.73M (-434.17%)
What is Immunome, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of IMNM is -$46.48M
What is the all-time high quarterly EBIT for Immunome, Inc.?
Immunome, Inc. all-time high quarterly earnings before interest & taxes is -$2.65M
What is Immunome, Inc. quarterly EBIT year-on-year change?
Over the past year, IMNM quarterly earnings before interest & taxes has changed by -$12.78M (-37.93%)
What is Immunome, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of IMNM is -$190.53M
What is the all-time high TTM EBIT for Immunome, Inc.?
Immunome, Inc. all-time high TTM earnings before interest & taxes is -$2.72M
What is Immunome, Inc. TTM EBIT year-on-year change?
Over the past year, IMNM TTM earnings before interest & taxes has changed by -$118.00M (-162.70%)